Pharmaceutical Management Information System: Support Supervision Report, October to December 2013, Cameroon

The report is a result of the SIAPS Program's efforts to improve the availability of quality pharmaceutical products and effective pharmaceutical services in Cameroon. The SIAPS Program aims to achieve desired health outcomes by improving governance, building capacity for pharmaceutical management and services, addressing information needed for decision-making in the pharmaceutical sector, strengthening financing strategies and mechanisms to improve access to medicines, and increasing quality pharmaceutical services. The program's result areas include improving inventory management, addressing ARV consumption, and enhancing patient information. The report presents the results of the SIAPS Program's interventions in Cameroon during the quarter October to December 2013. The program's key interventions include improving inventory management, enhancing ARV consumption, and increasing patient information. The report highlights the progress made in these areas, including the improvement in inventory management, the increase in ARV consumption, and the enhancement of patient information. The report also presents the results of the SIAPS Program's support supervision activities in Cameroon during the quarter October to December 2013. The program's support supervision activities included monitoring the implementation of the PMIS, providing technical assistance to health facilities, and conducting quarterly feedback reports. The report highlights the progress made in these areas, including the improvement in the completeness of health facility reports, the increase in the percentage of health facilities with medicine on pallets, and the enhancement of inventory management. The report also presents the results of the SIAPS Program's analysis of ARV consumption in Cameroon during the quarter October to December 2013. The analysis highlights the trend of ARV consumption, the estimated days of stock of LPV/r 200/50 mg and ATV/r 300/100 mg, and the estimated number of months of stock of pediatric ARVs at ART health facilities. The report also presents the results of the SIAPS Program's analysis of patient information in Cameroon during the quarter October to December 2013. The analysis highlights the trend of patients accessing treatment in Cameroon, the trend of ART patient trends by region, and the trend of the number of patients in SIAPS-supported health facilities in Cameroon. The report concludes by highlighting the progress made by the SIAPS Program in improving the availability of quality pharmaceutical products and effective pharmaceutical services in Cameroon. The report also presents recommendations for follow-up actions needed to sustain the progress made and to address the challenges faced by the program. The report also includes annexes that provide additional information on the health facilities supervised in January and February 2014, the trend of the consumption of ARV per region (Oct-Dec 2013), the quantity of ARV available at the day of the visit, and the report on the distribution of Stock Card, Reception PV, Stock out file, and inventory during Quarter 1 support supervision. The report also includes tables and figures that provide additional information on the patient distribution by region in December 2013, the percentage of adult patients on first-line ARVs, the follow-up recommendations, and the trend of the percentage of patients on adult first-line regimens in different regions. Overall, the report provides a comprehensive overview of the progress made by the SIAPS Program in improving the availability of quality pharmaceutical products and effective pharmaceutical services in Cameroon during the quarter October to December 2013. The report highlights the challenges faced by the program and presents recommendations for follow-up actions needed to sustain the progress made and to address the challenges faced by the program.